Maycotte Paola, Jones Kenneth L, Goodall Megan L, Thorburn Jacqueline, Thorburn Andrew
Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado.
Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado.
Mol Cancer Res. 2015 Apr;13(4):651-8. doi: 10.1158/1541-7786.MCR-14-0487. Epub 2015 Jan 8.
Autophagy is a mechanism by which cells degrade cellular material to provide nutrients and energy for survival during stress. The autophagy is thought to be a critical process for cancer stem cell (CSC) or tumor-initiating cell maintenance but the mechanisms by which autophagy supports survival of CSCs remain poorly understood. In this study, inhibition of autophagy by knockdown of ATG7 or BECN1 modified the CD44(+)/CD24(low/-) population in breast cancer cells by regulating CD24 and IL6 secretion. In a breast cancer cell line that is independent of autophagy for survival, autophagy inhibition increased IL6 secretion to the media. On the other hand, in an autophagy-dependent cell line, autophagy inhibition decreased IL6 secretion, cell survival, and mammosphere formation. In these cells, IL6 treatment or conditioned media from autophagy-competent cells rescued the deficiency in mammosphere formation induced by autophagy inhibition. These results reveal that autophagy regulates breast CSC maintenance in autophagy-dependent breast cancer cells by modulating IL6 secretion implicating autophagy as a potential therapeutic target in breast cancer.
Modulation of autophagy in breast cancer has different and even opposite effects, indicating the need for a selection strategy when trying to manipulate autophagy in the context of cancer therapy.
自噬是一种细胞降解细胞物质以在应激期间提供营养和能量以维持生存的机制。自噬被认为是癌症干细胞(CSC)或肿瘤起始细胞维持的关键过程,但自噬支持CSCs存活的机制仍知之甚少。在本研究中,通过敲低ATG7或BECN1抑制自噬,通过调节CD24和IL6分泌改变了乳腺癌细胞中的CD44(+)/CD24(low/-)群体。在一个不依赖自噬生存的乳腺癌细胞系中,自噬抑制增加了IL6向培养基中的分泌。另一方面,在一个依赖自噬的细胞系中,自噬抑制降低了IL6分泌、细胞存活和乳腺球形成。在这些细胞中,IL6处理或来自有自噬能力细胞的条件培养基挽救了自噬抑制诱导的乳腺球形成缺陷。这些结果表明,自噬通过调节IL6分泌来调节依赖自噬的乳腺癌细胞中的乳腺CSC维持,这意味着自噬是乳腺癌潜在的治疗靶点。
乳腺癌中自噬的调节具有不同甚至相反的作用,这表明在癌症治疗中试图操纵自噬时需要一种选择策略。